In adults, the term glioblastoma is now reserved only for IDH‐wildtype tumors and will always be graded as 4, whereas IDH‐mutated astrocytomas present a distinct progressive disease with WHO grade rising from 2 to 4. This evidence concerns the gene IDH1 and glioblastoma.